A homozygous


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
12 2020
Historique:
received: 09 08 2019
revised: 19 02 2020
accepted: 22 02 2020
pubmed: 18 3 2020
medline: 6 7 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

UBA5 is the activating enzyme of UFM1 in the ufmylation post-translational modification system. Different neurological phenotypes have been associated with We describe a large multigenerational consanguineous family presenting with a severe congenital neuropathy causing early death in infancy. Whole exome sequencing and linkage analysis identified a novel homozygous This report expands the phenotypical spectrum of UBA5 mutations to include fatal peripheral neuropathy.

Sections du résumé

BACKGROUND
UBA5 is the activating enzyme of UFM1 in the ufmylation post-translational modification system. Different neurological phenotypes have been associated with
METHODS AND RESULTS
We describe a large multigenerational consanguineous family presenting with a severe congenital neuropathy causing early death in infancy. Whole exome sequencing and linkage analysis identified a novel homozygous
CONCLUSION
This report expands the phenotypical spectrum of UBA5 mutations to include fatal peripheral neuropathy.

Identifiants

pubmed: 32179706
pii: jmedgenet-2019-106496
doi: 10.1136/jmedgenet-2019-106496
doi:

Substances chimiques

Proteins 0
UBA5 protein, human 0
UFM1 protein, human 0
Ubiquitin-Activating Enzymes EC 6.2.1.45

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

835-842

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Macarena Cabrera-Serrano (M)

Department of Neurology, Neuromuscular Unit and Instituto de Biomedicina de Sevilla/CSIC, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia.
Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

David Joseph Coote (DJ)

Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia.

Dimitar Azmanov (D)

Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia.
Department of Diagnostic Genomics, PathWest, QEII Medical Centre, Perth, Western Australia, Australia.

Hayley Goullee (H)

Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia.

Erik Andersen (E)

Pediatrics, University of Otago Wellington, Wellington, New Zealand.
Department of Neurology and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.

Catriona McLean (C)

Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia.

Mark Davis (M)

Department of Diagnostic Genomics, PathWest, QEII Medical Centre, Perth, Western Australia, Australia.

Ryosuke Ishimura (R)

Department of Physiology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Zornitza Stark (Z)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.

Jean-Michel Vallat (JM)

Reference center for peripheral neuropathies, University Hospital, Limoges, France.

Masaaki Komatsu (M)

Department of Physiology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Andrew Kornberg (A)

Department of Neurology and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.

Monique Ryan (M)

Department of Neurology and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.

Nigel G Laing (NG)

Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia.

Gina Ravenscroft (G)

Centre of Medical Research, The University of Western Australia and the Harry Perkins Institute for Medical Research, Perth, Western Australia, Australia gina.ravenscroft@perkins.uwa.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH